CASP3 and amyotrophic lateral sclerosis: Expression levels of activated caspase-3 was 27% higher in untreated ALS-SOD1G85R MNs compared to SOD1G85G MNs, but was reduced almost to the level of the SOD1G85G group by BP treatment (Fig 5C and 5D).